Prebiotics Do Not Influence the Severity of Atopic Dermatitis in Infants: A Randomised Controlled Trial
Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu klinické zkoušky, časopisecké články, randomizované kontrolované studie, práce podpořená grantem
PubMed
26571488
PubMed Central
PMC4646669
DOI
10.1371/journal.pone.0142897
PII: PONE-D-13-50975
Knihovny.cz E-zdroje
- MeSH
- antropometrie MeSH
- atopická dermatitida patologie prevence a kontrola MeSH
- dvojitá slepá metoda MeSH
- ekzém metabolismus patologie MeSH
- feces MeSH
- kojenec MeSH
- lidé MeSH
- náhražky mateřského mléka MeSH
- oligosacharidy terapeutické užití MeSH
- potravní doplňky MeSH
- prebiotika * MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- oligosacharidy MeSH
- prebiotika * MeSH
UNLABELLED: The objective was to evaluate the effects of a hypoallergenic (HA) formula supplemented with prebiotic galacto-oligosaccharides on the severity of atopic manifestations. A randomised clinical trial was conducted. The control group was infants, fed with hypoallergenic formula and without supplementation. The duration of the study was six months. The primary outcome of the study was a difference in the severity of atopic dermatitis measured using SCORAD (Scoring Atopic Dermatitis) criteria. Secondary outcomes were anthropometry (length, weight, and head circumference), together with the tolerance and incidence of infections. Both groups showed a decrease of average SCORAD values, but no statistically significant difference between the evaluated groups was observed. There were no statistically significant differences in anthropometry, or the tolerance or incidence of infections. Although there is no evidence, that consumption of a hypoallergenic infant formula enriched with prebiotic galacto-oligosaccharides had any effect on SCORAD, it was safe and well tolerated. TRIAL REGISTRATION: www.clinicaltrials.gov NCT 02077088.
Institute of Endocrinology Prague Czech Republic
Paediatrics Department Vitkovice Hospital Ostrava Czech Republic
Zobrazit více v PubMed
Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microflora of infants—composition of fecal flora in breast-fed and bottle-fed infants. Microbiology and Immunology 28: 975–986. PubMed
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota—introducing the concept of prebiotics. Journal of Nutrition 125: 1401–1412. PubMed
Fanaro S, Marten B, Bagna R, Vigi V, Fabris C, Pena-Quintana L, et al. (2009) Galacto-oligosaccharides Are Bifidogenic and Safe at Weaning: A Double-blind Randomized Multicenter Study. Journal of Pediatric Gastroenterology and Nutrition 48: 82–88. 10.1097/MPG.0b013e31817b6dd2 PubMed DOI
Collins MD, Gibson GR (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. American Journal of Clinical Nutrition 69: 1052S–1057S. PubMed
Ben X-M, Li J, Feng Z-T, Shi S-Y, Lu Y-D, Chen R, et al. (2008) Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal Bifidobacteria and Lactobacilli. World Journal of Gastroenterology 14: 6564–6568. PubMed PMC
Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA (1998) Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 101. PubMed
Niggemann B, Sielaff B, Beyer K, Binder C, Wahn U (1999) Outcome of double-blind, placebo-controlled food challenge tests in 107 children with atopic dermatitis. Clinical and Experimental Allergy 29: 91–96. PubMed
Sampson HA, McCaskill CC (1985) Food hypersensitivity and atopic dermatitis—Evaluation of 113 patients. Journal of Pediatrics 107: 669–675. PubMed
Host A, Koletzko B, Dreborg S, Muraro A, Wahn U, Aggett P, et al. (1999) Dietary products used in infants for treatment and prevention of food allergy. Joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Archives of Disease in Childhood 81: 80–84. PubMed PMC
Rzehak P, Sausenthaler S, Koletzko S, Reinhardt D, von Berg A, Kraemer U, et al. (2009) Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition 89: 1846–1856. 10.3945/ajcn.2008.27373 PubMed DOI
Rzehak P, Sausenthaler S, Koletzko S, Reinhardt D, von Berg A, Kraemer U, et al. (2011) Long-term effects of hydrolyzed protein infant formulas on growth-extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition 94: 1803S–1807S. 10.3945/ajcn.110.000679 PubMed DOI
van Hoffen E, Ruiter B, Faber J, M'Rabet L, Knol EF, Stahl B, et al. (2009) A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Allergy 64: 484–487. 10.1111/j.1398-9995.2008.01765.x PubMed DOI
Grueber C, Arslanoglu S, Piemontese P, Eisses A, Macheiner M, et al. (2008) Prevention of early atopic dermatitis by an infant formula supplemented with immunoactive prebiotics in low atopy risk infants. Allergy 63: 615–615.
EFSA Panel on Dietetic Products, Nutrition and Allergies (2009) Scientific Opinion on the substantiation of a health claim related to Immunofortis® and strengthening of the baby’s immune system. EFSA J 8(2): 1430 10.2903/j.efsa.2010.1430 DOI
Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G (2008) Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. Journal of Nutrition 138: 1091–1095. PubMed
Meloun M, Hill M, Militky J, Kupka K (2000) Transformation in the PC-aided biochemical data analysis. Clinical Chemistry and Laboratory Medicine 38: 553–559. PubMed
Meloun M, Militky J, Hill M, Brereton RG (2002) Crucial problems in regression modelling and their solutions. Analyst 127: 433–450. PubMed
Schulz KF, Altman DG, Moher D (2011) CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials RESPONSE. Annals of Internal Medicine 154: 291–292. PubMed
Nakamura N, Gaskins HR, Collier CT, Nava GM, Rai D, Petschow B, et al. (2009) Molecular Ecological Analysis of Fecal Bacterial Populations from Term Infants Fed Formula Supplemented with Selected Blends of Prebiotics. Applied and Environmental Microbiology 75: 1121–1128. 10.1128/AEM.02359-07 PubMed DOI PMC
Le Huerou-Luron I, Blat S, Boudry G (2010) Breast- v. formula-feeding: impacts on the digestive tract and immediate and long-term health effects. Nutrition Research Reviews 23: 23–36. 10.1017/S0954422410000065 PubMed DOI
van der Aa LB, Heymans HS, van Aalderen WM, Smitt JHS, Knol J, Ben Amor K et al. (2010) Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial. Clinical and Experimental Allergy 40: 795–804. 10.1111/j.1365-2222.2010.03465.x PubMed DOI
Severity scoring of atopic dermatitis: the SCORAD index(1993) Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology (Basel, Switzerland) 186: 23–31. PubMed
ClinicalTrials.gov
NCT02077088